The American College of Obstetrics and Gynecologists, and the Centers for Disease Control and Prevention, recommend all males and females aged 11-26 years be vaccinated against HPV.
The vaccine protects against cancers caused by HPV infection, most notably cervical, as well as anal, vaginal, vulvar, oropharyngeal, penile, and anogenital warts.
The optimal age of vaccination for males and females is 11-12 years old, and prior to onset of sexual activity, but the vaccine is approved to start as early as age 9. For ages under 15 years old, the vaccine is given in 2 doses, 6 months to 1 year apart. For ages over 15, the vaccine is delivered in 3 doses, at 0 months, 1-2 months, then 6 months.
Because the vaccine does not provide complete coverage against all carcinogenic HPV types, regular cervical cancer screenings, use of a diaphragm or condom, and smoking cessation are recommended preventative measures (Papadakis, McPhee, & Rabow, 2021).
Cox, J. T., & Palefsky, J. M. (2021, December 17). Human papillomavirus vaccination. UpToDate. Retrieved January 11, 2022, from https://www-uptodate-com.proxy.westernu.edu/contents/human-papillomavirus-vaccination?search=hpv&source=search_result&selectedTitle=2~150&usage_type=default&display_rank=2#H1664119832
Papadakis M.A., & McPhee S.J., & Rabow M.W.(Eds.), (2021). Current Medical Diagnosis & Treatment 2021. McGraw Hill. https://accessmedicine.mhmedical.com/content.aspx?bookid=2957§ionid=249359825